Skip to main content

Clinical trial D5660C00004

A Phase 1b/2, Open-Label, Multicentre Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumour Activity of MEDI4736 in Combination With AZD9150 or AZD5069 in Patients With Advanced Solid Malignancies and Subsequently Comparing AZD9150 and AZD5069 Both as Monotherapy and in Combination With MEDI4736 as Second Line Treatment in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Organ Bones - soft tissue
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 1/2
Academic trial Non
Sponsor AstraZeneca
EudraCT Identifier 2015-002525-19
Inclusion criteria At least one measurable lesion
Last update